Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387310033> ?p ?o ?g. }
- W4387310033 abstract "Background Diffuse large B-cell lymphoma (DLBCL) is an aggressive and the most common type of non-Hodgkin lymphoma (NHL). The clinical use of rituximab has improved the treatment response and survival of patients with DLBCL. The introduction of rituximab biosimilar into healthcare system has helped in providing a cost-effective treatment to B-cell lymphoid malignancies as standard of care and has improved access to patients worldwide. The aim of this study was to observe the real-world effectiveness and safety of Reditux™ and Ristova ® in DLBCL patients. Methods Observational study in adults with DLBCL receiving Reditux™ or Ristova ® across 29 centers in India (2015–2022). Effectiveness and safety were assessed up to 2 years after first dose. Results Out of 1,365 patients considered for analysis, 1,250 (91.6%) were treated with Reditux™ and 115 (8.42%) with Ristova ® . At 2 years, progression-free survival (PFS) 69% [hazard ratio (HR), 1.16; 95% CI, 0.80–1.67], overall survival (OS) 78.7% (HR, 1.20; 95% CI, 0.78–1.86), response rates, quality of life (QoL), and overall safety in both the cohorts were comparable. The best overall response rate (BORR) at 6 months was comparable with no statistically significant differences between the Reditux™ and the Ristova ® cohorts (89.2% vs. 94.3%). In multivariate analysis, BCL-2 and VAS were significant prognostic factors for PFS. Conclusion Reditux™ and Ristova ® were comparable in real-world setting. Clinical Trial Registration ISRCTN registry, identifier (ISRCTN13301166)" @default.
- W4387310033 created "2023-10-04" @default.
- W4387310033 creator A5009463015 @default.
- W4387310033 creator A5014487667 @default.
- W4387310033 creator A5039815428 @default.
- W4387310033 creator A5045323868 @default.
- W4387310033 creator A5049504956 @default.
- W4387310033 creator A5054430198 @default.
- W4387310033 creator A5055700353 @default.
- W4387310033 creator A5067147178 @default.
- W4387310033 creator A5069322918 @default.
- W4387310033 creator A5072931179 @default.
- W4387310033 date "2023-10-03" @default.
- W4387310033 modified "2023-10-05" @default.
- W4387310033 title "Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era" @default.
- W4387310033 cites W1986159244 @default.
- W4387310033 cites W2008356322 @default.
- W4387310033 cites W2018071905 @default.
- W4387310033 cites W2042693868 @default.
- W4387310033 cites W2045399297 @default.
- W4387310033 cites W2052235781 @default.
- W4387310033 cites W2101648653 @default.
- W4387310033 cites W2129272684 @default.
- W4387310033 cites W2133201432 @default.
- W4387310033 cites W2139204503 @default.
- W4387310033 cites W2140065103 @default.
- W4387310033 cites W2147246240 @default.
- W4387310033 cites W2158267770 @default.
- W4387310033 cites W2468171191 @default.
- W4387310033 cites W2476621440 @default.
- W4387310033 cites W2477255711 @default.
- W4387310033 cites W2495508741 @default.
- W4387310033 cites W2588390132 @default.
- W4387310033 cites W2598149423 @default.
- W4387310033 cites W2758950812 @default.
- W4387310033 cites W2760907988 @default.
- W4387310033 cites W2782772365 @default.
- W4387310033 cites W2790947864 @default.
- W4387310033 cites W2806838331 @default.
- W4387310033 cites W2898518424 @default.
- W4387310033 cites W2906672490 @default.
- W4387310033 cites W2966512175 @default.
- W4387310033 cites W2992331654 @default.
- W4387310033 cites W3006227285 @default.
- W4387310033 cites W3015996517 @default.
- W4387310033 cites W3017271278 @default.
- W4387310033 cites W3039618283 @default.
- W4387310033 cites W3157290121 @default.
- W4387310033 cites W3181774160 @default.
- W4387310033 cites W3186906131 @default.
- W4387310033 cites W4292528167 @default.
- W4387310033 doi "https://doi.org/10.3389/fonc.2023.1248723" @default.
- W4387310033 hasPublicationYear "2023" @default.
- W4387310033 type Work @default.
- W4387310033 citedByCount "0" @default.
- W4387310033 crossrefType "journal-article" @default.
- W4387310033 hasAuthorship W4387310033A5009463015 @default.
- W4387310033 hasAuthorship W4387310033A5014487667 @default.
- W4387310033 hasAuthorship W4387310033A5039815428 @default.
- W4387310033 hasAuthorship W4387310033A5045323868 @default.
- W4387310033 hasAuthorship W4387310033A5049504956 @default.
- W4387310033 hasAuthorship W4387310033A5054430198 @default.
- W4387310033 hasAuthorship W4387310033A5055700353 @default.
- W4387310033 hasAuthorship W4387310033A5067147178 @default.
- W4387310033 hasAuthorship W4387310033A5069322918 @default.
- W4387310033 hasAuthorship W4387310033A5072931179 @default.
- W4387310033 hasBestOaLocation W43873100331 @default.
- W4387310033 hasConcept C126322002 @default.
- W4387310033 hasConcept C143998085 @default.
- W4387310033 hasConcept C159110408 @default.
- W4387310033 hasConcept C207103383 @default.
- W4387310033 hasConcept C23131810 @default.
- W4387310033 hasConcept C2778559949 @default.
- W4387310033 hasConcept C2779338263 @default.
- W4387310033 hasConcept C2779951463 @default.
- W4387310033 hasConcept C2780653079 @default.
- W4387310033 hasConcept C44249647 @default.
- W4387310033 hasConcept C535046627 @default.
- W4387310033 hasConcept C59491497 @default.
- W4387310033 hasConcept C71924100 @default.
- W4387310033 hasConceptScore W4387310033C126322002 @default.
- W4387310033 hasConceptScore W4387310033C143998085 @default.
- W4387310033 hasConceptScore W4387310033C159110408 @default.
- W4387310033 hasConceptScore W4387310033C207103383 @default.
- W4387310033 hasConceptScore W4387310033C23131810 @default.
- W4387310033 hasConceptScore W4387310033C2778559949 @default.
- W4387310033 hasConceptScore W4387310033C2779338263 @default.
- W4387310033 hasConceptScore W4387310033C2779951463 @default.
- W4387310033 hasConceptScore W4387310033C2780653079 @default.
- W4387310033 hasConceptScore W4387310033C44249647 @default.
- W4387310033 hasConceptScore W4387310033C535046627 @default.
- W4387310033 hasConceptScore W4387310033C59491497 @default.
- W4387310033 hasConceptScore W4387310033C71924100 @default.
- W4387310033 hasLocation W43873100331 @default.
- W4387310033 hasOpenAccess W4387310033 @default.
- W4387310033 hasPrimaryLocation W43873100331 @default.
- W4387310033 hasRelatedWork W1598567296 @default.
- W4387310033 hasRelatedWork W1996279342 @default.
- W4387310033 hasRelatedWork W2012238656 @default.
- W4387310033 hasRelatedWork W2745838652 @default.